DOSE INTENSIFICATION OF CARBOPLATIN AND ETOPOSIDE AS FIRST-LINE COMBINATION CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER

被引：4

作者：

ELLIS, PA ^{[1
]}

TALBOT, DC ^{[1
]}

PRIEST, K ^{[1
]}

JONES, AL ^{[1
]}

SMITH, IE ^{[1
]}

机构：

[1] ROYAL MARSDEN HOSP,SUTTON SM2 5PT,SURREY,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷 / 11期

关键词：

D O I：

10.1016/0959-8049(95)00396-Z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1888 / 1889

页数：2

共 9 条

[1] CARBOPLATIN (CBDCA, JM-8) AND VP-16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER [J].

BISHOP, JF ;

RAGHAVAN, D ;

STUARTHARRIS, R ;

MORSTYN, G ;

ARONEY, R ;

KEFFORD, R ;

YUEN, K ;

LEE, J ;

GIANOUTSOS, P ;

OLVER, IN ;

ZALCBERG, J ;

BALL, D ;

BULL, C ;

FOX, R .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) :1574-1578

[2] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[3] VP-16 AND CISPLATIN AS 1ST-LINE THERAPY FOR SMALL-CELL LUNG-CANCER [J].

EVANS, WK ;

SHEPHERD, FA ;

FELD, R ;

OSOBA, D ;

DANG, P ;

DEBOER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1471-1477

[4] VP-16 AND CARBOPLATIN IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE SMALL CELL LUNG-CANCER - A STUDY OF THE NATIONAL CANCER INSTITUTE OF CANADA CLINICAL-TRIALS GROUP [J].

EVANS, WK ;

EISENHAUER, E ;

HUGHES, P ;

MAROUN, JA ;

AYOUB, J ;

SHEPHERD, FA ;

FELD, R .

BRITISH JOURNAL OF CANCER, 1988, 58 (04) :464-468

[5] RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS CISPLATIN AND ETOPOSIDE VERSUS ALTERNATION OF THESE REGIMENS IN SMALL-CELL LUNG-CANCER [J].

FUKUOKA, M ;

FURUSE, K ;

SAIJO, N ;

NISHIWAKI, Y ;

IKEGAMI, H ;

TAMURA, T ;

SHIMOYAMA, M ;

SUEMASU, K .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (12) :855-861

[6] CONCURRENT CHEMOTHERAPY - RADIOTHERAPY FOR LIMITED SMALL-CELL LUNG-CARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY [J].

MCCRACKEN, JD ;

JANAKI, LM ;

CROWLEY, JJ ;

TAYLOR, SA ;

GIRI, PGS ;

WEISS, GB ;

GORDON, W ;

BAKER, LH ;

MANSOURI, A ;

KUEBLER, JP .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :892-898

[7] RANDOMIZED STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS ETOPOSIDE AND CISPLATIN VERSUS ALTERNATION OF THESE 2 REGIMENS IN EXTENSIVE SMALL-CELL LUNG-CANCER - A PHASE-III TRIAL OF THE SOUTHEASTERN CANCER STUDY-GROUP [J].

ROTH, BJ ;

JOHNSON, DH ;

EINHORN, LH ;

SCHACTER, LP ;

CHERNG, NC ;

COHEN, HJ ;

CRAWFORD, J ;

RANDOLPH, JA ;

GOODLOW, JL ;

BROUN, GO ;

OMURA, GA ;

GRECO, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) :282-291

[8] CARBOPLATIN (PARAPLATIN JM8) AND ETOPOSIDE (VP-16) AS 1ST-LINE COMBINATION THERAPY FOR SMALL-CELL LUNG-CANCER [J].

SMITH, IE ;

EVANS, BD ;

GORE, ME ;

VINCENT, MD ;

REPETTO, L ;

YARNOLD, JR ;

FORD, HT .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (02) :185-189

[9] URINARY-DERIVED MONOCYTE-COLONY STIMULATING FACTOR (P-100) FOLLOWING TREATMENT WITH CARBOPLATIN AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER (SCLC) [J].

VANHOEF, MEHM ;

RADFORD, JA ;

JONES, A ;

SMITH, IE ;

EARL, HM ;

WOLL, PJ ;

THATCHER, N .

ANNALS OF ONCOLOGY, 1993, 4 (10) :877-881

← 1 →